Kainic acid

About

Kainic acid is a potent excitatory amino acid analog derived from seaweed that acts as an agonist at kainate-type glutamate receptors in the nervous system. When administered systemically or directly into brain structures, it induces sustained seizure activity and selective neuronal damage, particularly in hippocampal regions, mimicking the pathology observed in human temporal lobe epilepsy (TLE). In neuroscience and robotics-assisted research, kainic acid is widely used to establish animal models of epilepsy — including in non-human primates — enabling researchers to study seizure mechanisms, basal ganglia dysfunction, and potential therapeutic interventions such as deep brain stimulation. Robot-assisted stereotaxic injection of kainic acid into precise brain targets, like the hippocampus and amygdala, allows highly reproducible model creation with minimal surgical variability. This matters because reliable disease models are foundational to developing and validating treatments for neurological disorders. Understanding kainic acid's pharmacological action also informs drug discovery workflows, including radioligand binding assays used to screen candidate compounds targeting glutamate receptor pathways.